Naseh Abdollahzade1,2, Maryam Majidinia3, Shirin Babri4,5. 1. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 2. Department of Physiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. 3. Solid Tumor Research Center, Urmia University of Medical Sciences, Urmia, Iran. majidinia.m@umsu.ac.ir. 4. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. babris@tbzmed.ac.ir. 5. Department of Physiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. babris@tbzmed.ac.ir.
Abstract
BACKGROUND: Arsenic is a natural element which exists in the environment in inorganic and organic forms. In humans, the main reason for the toxicity of arsenic is its uptake via water sources. As polluted water and the problems associated with it can be found in many countries. Therefore, considering all these positive effects of melatonin, this review is aimed at melatonin supplementation therapy on arsenic toxicity which seems to be a suitable therapeutic agent to eliminate the adverse effects of arsenic. METHODS AND RESULTS: It is seen in previous studies that chronic exposure to arsenic could cause serious dys functions of organs and induce different degrees of toxicities that is one of the first hazardous materials in the classification of substances by the United States Environmental Protection Agency so leads to costly cleanup operations burdening the economy. Arsenic harmfulness degree depends on the bioavailability, chemical form, valence state, detoxification, and metabolism of human body. The oxidative stress has a major role in arsenic-induced toxicity; on the other hand, it was discovered that melatonin is a powerful scavenger for free radical and it's an extensive-spectrum antioxidant. CONCLUSION: Due to its highly lipophilic and small size properties, melatonin accesses all intracellular organs by easily passing via the cell membrane and prevents protein, DNA damage, and lipid peroxidation. In particular, melatonin, by protecting and reducing oxidative stress in mitochondria, can normalize homeostasis and mitochondrial function and ultimately prevent apoptosis and cell death.
BACKGROUND: Arsenic is a natural element which exists in the environment in inorganic and organic forms. In humans, the main reason for the toxicity of arsenic is its uptake via water sources. As polluted water and the problems associated with it can be found in many countries. Therefore, considering all these positive effects of melatonin, this review is aimed at melatonin supplementation therapy on arsenic toxicity which seems to be a suitable therapeutic agent to eliminate the adverse effects of arsenic. METHODS AND RESULTS: It is seen in previous studies that chronic exposure to arsenic could cause serious dys functions of organs and induce different degrees of toxicities that is one of the first hazardous materials in the classification of substances by the United States Environmental Protection Agency so leads to costly cleanup operations burdening the economy. Arsenic harmfulness degree depends on the bioavailability, chemical form, valence state, detoxification, and metabolism of human body. The oxidative stress has a major role in arsenic-induced toxicity; on the other hand, it was discovered that melatonin is a powerful scavenger for free radical and it's an extensive-spectrum antioxidant. CONCLUSION: Due to its highly lipophilic and small size properties, melatonin accesses all intracellular organs by easily passing via the cell membrane and prevents protein, DNA damage, and lipid peroxidation. In particular, melatonin, by protecting and reducing oxidative stress in mitochondria, can normalize homeostasis and mitochondrial function and ultimately prevent apoptosis and cell death.
Authors: Jörg H Stehle; Anastasia Saade; Oliver Rawashdeh; Katrin Ackermann; Antje Jilg; Tamás Sebestény; Erik Maronde Journal: J Pineal Res Date: 2011-04-26 Impact factor: 13.007
Authors: Ramazan Uygur; Cevat Aktas; Veli Caglar; Emine Uygur; Hasan Erdogan; Oguz Aslan Ozen Journal: Toxicol Ind Health Date: 2013-12-06 Impact factor: 2.273
Authors: K Jomova; Z Jenisova; M Feszterova; S Baros; J Liska; D Hudecova; C J Rhodes; M Valko Journal: J Appl Toxicol Date: 2011-02-14 Impact factor: 3.446
Authors: Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter Journal: Cell Mol Life Sci Date: 2014-02-20 Impact factor: 9.261